Rosenzweig M, Seldin D, Remick DG, Skinner M, Quillen K, Oran B, Finn KT, Sanchorawala V. Febrile reactions occurring with second cycle of high-dose melphalan and SCT in patients with AL amyloidosis: a 'melphalan recall' reaction. Bone Marrow Transplant 2010, 45(1):21-4.
Rosenzweig M, Sawyer D, Ruberg F, Wright D, Sanchorawala V, Seldin D, Vita J, Lala R, Brenner D, Sam F, Skinner M. A trial of antioxidants to improve cardiac function in patients with AL amyloidosis and cardiac involvement. XIth International symposium on Amyloidosis. 2008 Skinner, M. Berk, J. Connors, L. Seldin D. Taylor and Francis Group , LLC pp. 295-297.
Rosenzweig M, Skinner M, Prokaeva T, Théberge R, Costello C, Drachman B, Connors L, A new transthyretin variant (Glu61Gly) associated with cardiomyopathy, Amyloid 2007, 14:1, 65-71
Sanchorawala V, Wright D, Rosenzweig M, Finn K, Fennessey S, Zeldis J, Skinner M and Seldin D. Lenalidomide and dexamethasone in the treatment of AL amyloidosis: results of a phase 2 trial. Blood 2007 109 492-496
Weichman K, Dember LM, Prokaeva T, Wright DG, Quillen K, Rosenzweig M, Skinner M, Seldin DC, Sanchorawala V. Clinical and molecular characteristics of patients with non-amyloid light chain deposition disorders, and outcome following treatment with high-dose melphalan and autologous stem cell transplantation. Bone Marrow Transplant. 2006 Sep;38 (5):339-43.
This is a partial list. Full publications list available upon request. Information on this page may be self-reported and is subject to change at any time. Last updated: 02/12.